Lv1
30 积分 2026-01-17 加入
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura
1个月前
已完结
A single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia
1个月前
已完结
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies
6个月前
已完结
Clinical and genetic characteristics of 40 patients with nonmuscle myosin heavy chain 9-related disease (MYH9-RD) misdiagnosed as immune thrombocytopenia: a retrospective analysis in China
6个月前
已完结
LncRNA HCG11 regulates selinexor sensitivity in multiple myeloma
6个月前
已完结
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
7个月前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
7个月前
已完结
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
7个月前
已完结
皖公网安备34019202002308
